- Home
- ANEB vs TURN Comparison
ANEB vs TURN Comparison
Compare ANEB & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- TURN
- Stock Information
- Founded
- ANEB 2020
- TURN 1981
- Country
- ANEB United States
- TURN United States
- Employees
- ANEB N/A
- TURN N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- ANEB Health Care
- TURN Finance
- Exchange
- ANEB Nasdaq
- TURN Nasdaq
- Market Cap
- ANEB 36.7M
- TURN 39.6M
- IPO Year
- ANEB 2021
- TURN N/A
- Fundamental
- Price
- ANEB $1.43
- TURN $3.72
- Analyst Decision
- ANEB Buy
- TURN
- Analyst Count
- ANEB 1
- TURN 0
- Target Price
- ANEB $8.00
- TURN N/A
- AVG Volume (30 Days)
- ANEB 25.7K
- TURN 38.0K
- Earning Date
- ANEB 02-14-2025
- TURN 05-12-2025
- Dividend Yield
- ANEB N/A
- TURN N/A
- EPS Growth
- ANEB N/A
- TURN N/A
- EPS
- ANEB N/A
- TURN N/A
- Revenue
- ANEB N/A
- TURN $194,813.00
- Revenue This Year
- ANEB N/A
- TURN N/A
- Revenue Next Year
- ANEB N/A
- TURN N/A
- P/E Ratio
- ANEB N/A
- TURN N/A
- Revenue Growth
- ANEB N/A
- TURN 254.25
- 52 Week Low
- ANEB $0.80
- TURN $3.12
- 52 Week High
- ANEB $3.30
- TURN $4.40
- Technical
- Relative Strength Index (RSI)
- ANEB 58.07
- TURN 36.71
- Support Level
- ANEB $0.91
- TURN $3.67
- Resistance Level
- ANEB $1.70
- TURN $3.90
- Average True Range (ATR)
- ANEB 0.19
- TURN 0.11
- MACD
- ANEB 0.04
- TURN -0.03
- Stochastic Oscillator
- ANEB 65.91
- TURN 28.26
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.